📰 Clinical Development News
Page 23 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
May 2, 2024
CHICAGO-ADM , a leader in microbiome research and solutions, has announced the publication of a new study on probiotic Bifidobacterium longum CECT 7347 * and postbiotic heat-treated...
May 2, 2024
In the broad healthcare landscape, one area that has historically been overlooked and under-prioritized is women's health.
May 1, 2024
PRESS RELEASE Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development ...
May 1, 2024
The approval was based on data from an open-label clinical trial that included 33 virologically-suppressed pregnant adults.
May 1, 2024
- Pepper Bio will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib in the US, Europe, Japan, and All Other Global Markets Excluding...
May 1, 2024
/PRNewswire/ -- EverGlade Consulting is pleased to announce the appointment of Dr. Joe Larsen as Managing Director, effective April 2024. Dr. Larsen brings...
April 30, 2024
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The
April 30, 2024
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The
April 30, 2024
Quarterly Activity Report Q3 FY24 Highlights • Completion of enrolment in first trial of sozinibercepts Phase 3 pivotal program...
April 30, 2024
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided ...